≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Carcinoma in situ of skin of lower limb, including hip

Endpoint Browser

CD2_INSITU_SKIN_LOWERLIMB_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D04.7&
  • Hospital discharge: ICD-9 — 2327
  • Cause of death: ICD-10 — D04.7&
  • Cause of death: ICD-9 — 2327

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D04
Name in latin
Carcinoma in situ cutis pelvis

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 630 371 259
Unadjusted period prevalence (%) 0.12 0.13 0.11
Median age at first event (years) 74.73 73.77 76.10

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
553
Matched controls
5529
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
4503599627370496.0
323.0
552
*
L57.0
ICD-10 Finland
Actinic keratosis
40.2
277.0
383
293
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
35.8
244.7
339
234
TQW99
NOMESCO Finland
Other minor procedure on skin
62.1
219.9
255
75
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
857.4
191.1
177
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
45.5
177.7
220
79
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
59.6
156.3
182
45
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
912.2
147.2
138
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
155.5
127.5
131
11
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
113.5
105
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
54.2
112.2
133
32
R23.8
ICD-10 Finland
Other and unspecified skin changes
10.1
109.1
256
434
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
21.6
106.8
163
105
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
589.6
102.0
98
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
243.3
100.1
100
5
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
21.6
97.5
148
92
ZXC50
NOMESCO Finland
Cryotherapy
28.9
94.5
130
58
ZXC20
NOMESCO Finland
Use of chemical agents
42.8
93.3
116
34
ZXC15
NOMESCO Finland
Use of photodynamic technique
97.3
89.5
97
12
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
38.7
88.1
112
36
D06BB10
ATC
imiquimod; topical
18.8
81.2
129
88
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
75.8
71
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
823.2
75.1
72
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
22.6
72.4
107
58
ZQZ00
NOMESCO Finland
Treatment of several skin areas
270.7
71.1
71
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
757.9
69.6
67
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
38.0
68.3
87
27
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
+∞
67.0
63
*
S18
ICPC
Laceration/cut
4.9
66.5
378
1688
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
66.0
62
*
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
190.0
65.6
67
*
ZZR00
NOMESCO Finland
Flap of skin
72.1
56.6
64
10
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
56.2
53
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
50.8
48
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
48.7
46
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
509.5
48.1
47
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
46.5
44
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
43.3
41
*
Z2221
NOMESCO Finland
Medical doctor
3.8
42.9
247
973
L82
ICD-10 Finland
Seborrhoeic keratosis
4.4
40.1
174
526
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
113.4
39.3
42
*
127
Kela drug reimbursment
Transplant complication
54.2
38.2
45
9
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
36.9
35
*
XQ848
NOMESCO Finland
Dermatological photography
19.6
36.1
55
31
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
35.8
34
*
Z94.0
ICD-10 Finland
Kidney transplant status
55.1
34.9
41
8
115
Kela drug reimbursment
Breast cancer
+∞
34.7
33
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
61.4
34.7
40
7
S77
ICPC
Malignant neoplasm of skin
186.3
34.1
35
*
ZZA00
NOMESCO Finland
Split skin graft
12.6
34.0
62
55
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
33.7
32
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
32.9
192
729
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
342.3
32.2
32
*
SPAT1153
SPAT
Removal of sutures
3.0
31.6
252
1193
116
Kela drug reimbursment
Prostate cancer
+∞
31.6
30
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
74.4
31.2
35
5
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
+∞
30.5
29
*
130
Kela drug reimbursment
Malignant tumour
+∞
30.5
29
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
163.8
30.0
31
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
29.4
28
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
67.7
28.2
32
5
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
105.5
27.9
30
*
Z3231
NOMESCO Finland
Registered nurse
2.9
27.3
214
976
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
101.8
26.9
29
*
L04AD01
ATC
ciclosporin; systemic
27.4
26.5
36
14
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
272.6
25.9
26
*
E0000UV
ATC
NA
2.7
25.7
272
1476
S21
ICPC
Skin texture symptom/complaint
3.7
25.6
126
407
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
21.3
24.6
36
18
S29
ICPC
Skin symptom/complaint other
3.1
23.7
155
617
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
8.4
23.6
53
69
ZXE00
NOMESCO Finland
One hour or less
2.5
23.4
271
1523
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
15.6
23.3
38
26
WX002
NOMESCO Finland
Sedation and analgesia
2.9
23.1
177
779
HA1AA
NOMESCO Finland
X-ray mammography
8.3
23.1
52
68
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
23.1
22
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
23.1
22
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
23.0
308
1864
JN4BD
NOMESCO Finland
Extensive body CT
5.6
22.9
70
140
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
22.8
252
1373
R4110
NOMESCO Finland
Physiotherapy
2.7
22.7
196
928
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
47.1
22.6
27
6
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
65.3
22.0
25
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
10.5
21.5
42
43
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
21.0
20
*
L04AA01
ATC
[U] ciclosporin; systemic
12.7
20.8
37
31
L02BG04
ATC
letrozole; oral
114.3
20.7
22
*
XQ845
NOMESCO Finland
Dermatoscopy
19.2
20.6
31
17
HAB40
NOMESCO Finland
Wedge excision of mammary gland
43.4
20.6
25
6
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
19.9
19
*
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
19.9
19
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
19.9
259
1506
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
18.6
19.8
30
17
L02AE02
ATC
leuprorelin; implant, parenteral
207.0
19.7
20
*
H02AB02
ATC
dexamethasone; systemic
12.9
19.3
34
28
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
12.9
19.3
34
28
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
19.3
260
1529
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.1
18.9
61
130
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.9
18.8
131
534
L04AA06
ATC
mycophenolic acid; systemic
15.0
18.3
30
21
A12AA04
ATC
calcium carbonate; oral
12.0
18.2
33
29
A12BA01
ATC
potassium chloride; oral
3.9
18.2
78
221
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
34.2
18.1
23
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
18.0
130
541
TQW80
NOMESCO Finland
Local dermatologic skincare
9.4
17.9
37
42
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
17.8
17
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.5
17.3
164
796
D06BX02
ATC
ingenol mebutate; topical
11.2
17.2
32
30
WX110
NOMESCO Finland
Local anesthesy
2.2
17.1
358
2520
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
65.4
16.8
19
*
137
Kela drug reimbursment
Uraemia requiring dialysis
36.3
16.8
21
6
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
16.7
16
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.8
16.7
57
129
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
175.0
16.6
17
*
A04AA02
ATC
granisetron; systemic, transdermal
175.0
16.6
17
*
A11CC03
ATC
alfacalcidol; systemic
8.5
16.5
36
45
Z3226
NOMESCO Finland
Physiotherapist
2.6
16.4
139
633
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.4
16.2
49
97
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
16.2
98
359
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.0
16.2
34
40
B03XA01
ATC
erythropoietin; parenteral
49.0
16.1
19
*
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
49.0
16.1
19
*
WF002
NOMESCO Finland
Radical radiotherapy
61.8
15.8
18
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
L02BA01
ATC
tamoxifen; oral
+∞
15.7
15
*
L02BB03
ATC
bicalutamide; oral
+∞
15.7
15
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.4
15.6
32
36
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
87.6
15.6
17
*
D07AB08
ATC
desonide; topical
3.2
15.4
86
300
J01DB01
ATC
cefalexin; oral
2.3
15.3
447
3556
B01AB05
ATC
enoxaparin; parenteral
2.2
15.0
202
1152
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.1
14.8
33
43
205
Kela drug reimbursment
Chronic hypertension
2.1
14.8
258
1638
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
14.6
14
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
14.6
14
*
ZXA05
NOMESCO Finland
Left side
2.2
14.6
196
1111
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.0
14.4
30
35
A98
ICPC
Health maint/preventive medicine
3.4
14.1
520
4550
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.4
13.9
28
31
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
10.4
13.6
26
26
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
13.6
13
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
13.6
13
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
13.6
13
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
16.7
13.5
21
13
7151
FHL
Kidney transplantation
143.3
13.5
14
*
JN4AD
NOMESCO Finland
Body CT examination
4.7
13.0
44
99
DAB00
NOMESCO Finland
Excision of lesion of auricle
29.1
13.0
17
6
B07.9
ICD-10 Finland
Verruca simplex
6.9
13.0
32
49
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
12.7
87
345
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
71.5
12.6
14
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
71.5
12.6
14
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
71.5
12.6
14
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
71.5
12.6
14
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.6
12.6
29
40
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
32.9
12.6
16
5
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
12.5
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.5
12
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
12.5
12
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.1
12.2
48
126
L85.80
ICD-10 Finland
Hudhorn
27.4
12.1
16
6
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
12.0
95
408
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
11.9
150
813
S08
ICPC
Skin colour change
3.9
11.9
49
134
D02AE01
ATC
carbamide; topical
3.4
11.8
58
184
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
11.8
83
336
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.9
11.7
20
16
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
11.5
11
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
11.5
11
*
C44.79
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including hip or other unspecified histology
+∞
11.5
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.5
11
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
11.5
11
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
10.9
11.3
21
20
Z49.0
ICD-10 Finland
Preparatory care for dialysis
17.5
11.3
17
10
XX3DW
NOMESCO Finland
Time consuming IT work
4.0
11.2
45
121
D07AC01
ATC
betamethasone; topical
1.9
11.2
211
1341
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.3
11.1
21
21
A04AA01
ATC
ondansetron; systemic, rectal
6.2
11.0
29
49
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
10.8
57
191
XKD00
NOMESCO Finland
Uroflowmetry
2.4
10.5
99
467
N02BE01
ATC
paracetamol; systemic, rectal
2.2
10.5
483
4172
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
+∞
10.4
10
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
10.4
10
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.4
10
*
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
+∞
10.4
10
*
Y77
ICPC
Malignant neoplasm prostate
+∞
10.4
10
*
D04
ICD-10 Finland
Carcinoma in situ of skin
+∞
10.4
10
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
10.4
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.4
10
*
L04AX01
ATC
azathioprine; systemic
4.1
10.4
40
103
Z51.5
ICD-10 Finland
Palliative care
5.5
10.4
30
57
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
33.2
10.4
13
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.8
10.4
34
75
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
6.4
10.3
26
42
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
11.6
10.1
18
16
S82
ICPC
Naevus/mole
2.6
10.1
79
338
B05DA
ATC
Isotonic solutions
40.8
10.0
12
*
L03AA02
ATC
filgrastim; parenteral
40.8
10.0
12
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
10.0
137
766
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.9
9.9
40
108
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
9.9
281
2027
TQW40
NOMESCO Finland
Remowal of suture of skin
3.3
9.8
50
163
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
9.7
84
377
ZZA50
NOMESCO Finland
Full thickness skin graft
56.0
9.7
11
*
J01MA02
ATC
ciprofloxacin; systemic
1.8
9.6
236
1620
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
9.6
110
568
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
4.5
9.6
33
77
N02AX02
ATC
tramadol; systemic, rectal
1.8
9.4
242
1680
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
12.6
9.4
16
13
Z71.8
ICD-10 Finland
Other specified counselling
2.0
9.4
131
734
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.4
9
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
9.4
9
*
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
9.4
9
*
B01AB10
ATC
tinzaparin; parenteral
3.7
9.4
40
114
XF404
NOMESCO Finland
Ambulatory ECG
2.4
9.3
82
372
N18.0
ICD-10 Finland
End-stage renal disease
9.7
9.3
18
19
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
7.2
9.1
21
30
ZXA00
NOMESCO Finland
Right side
1.8
8.9
184
1185
WX320
NOMESCO Finland
Spinalanesthesy
1.9
8.8
150
905
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
8.8
141
830
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
4.8
8.7
28
61
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
50.8
8.7
10
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
50.8
8.7
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
8.7
124
698
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
11.8
8.6
15
13
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
8.6
173
1102
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
9.2
8.6
17
19
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
28.0
8.5
11
*
E000001
ATC
NA
2.0
8.4
119
668
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
91.4
8.4
9
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
8.3
8
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
8.3
8
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.3
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.3
8
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
8.3
8
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
+∞
8.3
8
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
QCA30
NOMESCO Finland
Electrocoagulation of skin of upper limb
+∞
8.3
8
*
S01GX01
ATC
cromoglicic acid; ophthalmic
2.1
8.3
98
512
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.6
8.2
20
31
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.2
8.2
43
144
H02AB04
ATC
methylprednisolone; systemic
2.1
8.2
97
506
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
8.2
188
1247
L17
ICPC
Foot/toe symptom/complaint
1.8
8.2
171
1100
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.9
8.1
10
*
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
33.9
8.1
10
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
8.0
64
277
RJ420
NOMESCO Finland
NA
22.4
8.0
11
5
N02AA05
ATC
oxycodone; systemic
2.2
8.0
85
420
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
8.0
121
695
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.4
8.0
18
25
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.5
7.9
36
109
UJF32
NOMESCO Finland
Coloscopy
1.8
7.9
163
1042
CBB30
NOMESCO Finland
Excision of lesion of eyelid
4.4
7.8
27
64
ZX112
NOMESCO Finland
Subcutaneous
15.3
7.7
12
8
B03XA02
ATC
darbepoetin alfa; parenteral
7.6
7.7
17
23
WZC30
NOMESCO Finland
Teaching
2.5
7.6
59
252
QAE99
SPAT
NA
18.7
7.6
11
6
KCD02
NOMESCO Finland
Transurethral resection of bladder
25.4
7.6
10
*
B05DB
ATC
Hypertonic solutions
25.4
7.6
10
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
25.4
7.6
10
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
5.9
7.6
20
35
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.9
7.6
20
35
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.7
7.6
51
199
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.4
7.5
35
108
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
81.1
7.4
8
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
81.1
7.4
8
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
81.1
7.4
8
*
C03CA01
ATC
furosemide; systemic
1.7
7.4
232
1673
L28
ICPC
Limited function/disability (L)
1.9
7.3
125
747
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
7.3
7
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
C44.69
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology
+∞
7.3
7
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
7.3
7
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
7.2
208
1465
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
7.2
45
168
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.2
167
1105
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
20.3
7.2
10
5
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
20.3
7.2
10
5
UKC02
NOMESCO Finland
Cystoscopy
2.0
7.1
102
572
A02BC02
ATC
pantoprazole; systemic
1.6
7.1
353
2866
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
7.1
59
262
S15
ICPC
Foreign body in skin
3.0
7.1
40
139
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
7.1
235
1717
D06BB03
ATC
aciclovir; topical
3.2
7.0
35
114
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.3
7.0
34
109
ZX120
NOMESCO Finland
Intravenous
2.7
7.0
48
191
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
7.0
132
817
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
6.8
6.9
16
24
C08CA02
ATC
felodipine; oral
2.0
6.8
87
467
M25.5
ICD-10 Finland
Pain in joint
1.8
6.8
144
925
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
40.5
6.8
8
*
RJ120
NOMESCO Finland
NA
40.5
6.8
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
40.5
6.8
8
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
40.5
6.8
8
*
L57
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation
16.9
6.8
10
6
C02CA01
ATC
prazosin; oral
4.5
6.7
22
50
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
6.7
84
446
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
6.7
55
242
D22
ICD-10 Finland
Melanocytic naevi
4.1
6.7
24
60
D02AX
ATC
Other emollients and protectives
3.8
6.7
26
70
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.9
6.7
39
142
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
6.6
40
149
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
6.6
182
1257
Z2446
NOMESCO Finland
Social worker
2.9
6.6
38
136
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
12.4
6.6
11
9
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
6.6
171
1161
S26
ICPC
Fear of cancer of skin
8.8
6.6
13
15
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
8.8
6.6
13
15
R50.9
ICD-10 Finland
Fever, unspecified
2.1
6.5
75
384
R31
ICD-10 Finland
Unspecified haematuria
2.2
6.5
64
307
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.1
6.5
34
116
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
6.5
155
1030
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.5
6.4
14
19
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
70.6
6.4
7
*
A79
ICPC
Malignancy NOS
70.6
6.4
7
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
70.6
6.4
7
*
L01BB01
ATC
NA
14.5
6.4
10
7
Z49.2
ICD-10 Finland
Other dialysis
14.5
6.4
10
7
-44
ICPC
Preventive immunization/medic
2.1
6.4
68
340
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
6.7
6.4
15
23
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
8.3
6.4
13
16
F16
ICPC
Eyelid symptom/complaint
3.3
6.3
30
95
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
6.3
58
269
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.4
6.3
12
13
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
18.3
6.3
9
5
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.2
6.3
22
54
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
WXQ44
NOMESCO Finland
Photodynamic therapy of lower limb
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
6.3
6
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
6.3
6
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
6.3
194
1382
TK800
NOMESCO Finland
Hemodialysis
5.1
6.2
18
36
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
5.8
6.2
16
28
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.8
6.2
16
28
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.4
6.2
28
86
R4120
NOMESCO Finland
Occupational therapy
2.6
6.2
43
173
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.8
6.1
19
41
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.5
6.1
26
76
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
6.1
57
269
WX402
NOMESCO Finland
General anaesthesia
2.1
6.1
68
347
C07AG02
ATC
carvedilol; oral
2.4
6.1
51
226
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
5.3
6.1
17
33
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
6.0
59
284
L12
ICPC
Hand/finger symptom/complaint
2.0
6.0
81
442
E000007
ATC
NA
2.9
6.0
35
127

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
299
312
17.34
280.03
2.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
514
1466
14.61
208.22
5.3
1.6
—
—
—
0
0
(4035726)
119
113
12.75
112.64
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
137
200
8.48
93.26
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
337
1588
3.41
50.57
8.1
4.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
402
2341
2.98
37.91
5.4
3.6
g/l
34.0
34.9
2.31
363
2146
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
112
306
4.24
37.35
2.8
1.4
ug/l
11.5
4.6
0.51
91
235
(3022096) Basophils/100 leukocytes in Blood
376
2135
2.89
36.78
9.2
5.0
%
0.7
0.7
0.42
352
1955
(3006504) Eosinophils/100 leukocytes in Blood
382
2197
2.88
36.29
9.2
4.9
%
2.6
2.9
2.21
356
2008
(3019069) Monocytes/100 leukocytes in Blood
382
2201
2.87
36.09
9.5
5.2
%
8.7
8.8
0.26
358
2018
(3013650) Neutrophils [#/volume] in Blood by Automated count
429
2641
2.96
35.50
11.7
5.6
e9/l
4.1
4.5
2.62
374
2257
(3002030) Lymphocytes/100 leukocytes in Blood
381
2238
2.78
33.90
9.5
5.2
%
26.5
26.0
0.28
355
2039
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
542
3864
3.88
33.72
10.1
5.1
u/l
80.7
77.4
1.10
512
3519
(3018010) Neutrophils/100 leukocytes in Blood
377
2215
2.75
33.32
9.1
5.0
%
58.1
58.7
0.38
351
2032
(3030467) Casts [#/volume] in Urine by Automated count
290
1499
2.73
33.05
4.6
3.1
e6/l
0.3
0.5
1.03
224
1134
(36304419) Bacteria [Presence] in Urine
282
1440
2.73
32.88
4.5
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
302
1611
2.68
32.06
4.6
3.1
e6/l
49.1
93.4
0.53
233
1234
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
339
1916
2.67
31.96
4.7
3.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
391
2373
2.71
31.83
8.6
4.8
e9/l
0.0
0.0
0.75
327
2007
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
403
2518
2.67
30.33
9.1
4.9
mmol/l
1.2
1.2
0.57
369
2207
(3001604) Monocytes [#/volume] in Blood
386
2363
2.64
30.29
8.7
4.8
e9/l
0.7
0.6
0.55
327
1987
(3018095) Leukocytes [#/volume] in Urine
330
1883
2.58
29.88
5.5
3.6
e6/l
118.9
110.7
0.06
238
1329
(3013115) Eosinophils [#/volume] in Blood
395
2456
2.63
29.83
8.9
4.9
e9/l
0.2
0.2
1.36
334
2104
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
429
2793
2.68
29.18
10.0
5.4
mmol/l
1.2
1.2
0.17
358
2364
(3019198) Lymphocytes [#/volume] in Blood
389
2417
2.59
29.16
8.8
4.9
e9/l
2.5
1.8
1.33
331
2071
(40758558) Short blood count panel - Blood
228
1134
2.58
26.95
8.5
4.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
267
1434
2.50
26.75
3.1
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
139
538
3.03
26.61
4.2
2.8
u/l
243.9
238.0
0.24
134
500
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
223
1105
2.58
26.49
2.8
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
186
844
2.71
26.42
3.8
2.9
e6/l
3.5
3.2
0.05
96
444
(3007853) Bacteria identified in Skin by Aerobe culture
144
575
2.95
26.03
2.3
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
36
48
7.89
25.71
4.9
4.2
iu/ml
197.8
350.2
—
6
6
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
388
2503
2.43
25.37
6.4
3.5
umol/l
12.5
11.8
0.71
373
2313
(3018418) pH of Serum or Plasma
289
1642
2.40
25.19
6.9
3.2
ph
7.4
7.4
0.24
52
268
(3021589) Normoblasts [#/volume] in Blood
344
2115
2.38
24.95
14.4
8.6
e9/l
0.0
0.0
0.12
273
1711
(3026782) Osmolality of Urine
214
1082
2.48
23.94
3.9
2.7
mosm/kgh2o
541.2
535.1
0.16
190
909
(3042936) Bacteria identified in Isolate by Culture
160
711
2.68
23.37
2.1
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
159
712
2.65
22.81
8.8
4.5
mmol/l
1.0
1.0
0.00
149
637
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
188
926
2.47
21.99
3.6
2.7
e6/l
0.6
1.9
2.47
97
523
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
569
4568
3.54
21.46
26.5
13.9
ml/min/173m2
65.8
70.2
4.99
501
3675
(3023368) Bacteria identified in Blood by Culture
262
1504
2.27
21.44
5.7
3.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
109
416
2.96
21.08
2.3
2.0
u/l
29.6
31.5
0.37
94
334
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
156
727
2.52
20.38
3.7
2.5
%
20.6
22.2
0.64
140
604
(3004789) Transferrin [Mass/volume] in Serum or Plasma
162
777
2.46
19.83
3.4
2.4
g/l
2.2
2.3
0.46
145
714
(3012095) Magnesium [Moles/volume] in Serum or Plasma
155
741
2.45
19.03
3.1
2.3
mmol/l
0.8
0.8
0.66
145
663
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
338
2220
2.13
19.00
2.6
2.3
nmol/l
83.1
80.9
0.70
300
1897
(3002385) Erythrocyte distribution width [Ratio]
504
3891
2.48
18.72
33.3
17.7
%
14.1
13.8
2.66
496
3772
(3000850) Epithelial cells [#/volume] in Urine
211
1159
2.23
18.72
3.5
2.4
e6/l
4.6
5.7
0.82
191
1006
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
330
2163
2.10
18.47
4.5
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
527
4164
2.62
18.41
31.1
16.8
%
38.7
38.2
0.75
360
2450
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
76
256
3.24
18.12
1.6
1.7
g/l
1.4
1.6
1.16
69
226
(3000991) Gas panel - Venous blood
106
437
2.71
17.59
10.4
6.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
609
5259
5.74
17.50
32.1
18.7
mmol/l
4.0
4.0
0.59
600
5090
(3015377) Calcium [Moles/volume] in Serum or Plasma
291
1848
2.07
17.43
4.3
2.1
mmol/l
2.4
2.4
1.07
250
1508
(3049717) Cytology report of Urine Cyto stain
56
159
3.77
17.35
2.6
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
584
4910
3.59
17.34
26.0
14.8
mg/l
26.7
25.5
0.37
499
3908
(3019550) Sodium [Moles/volume] in Serum or Plasma
608
5252
5.51
17.28
31.1
18.6
mmol/l
139.3
139.7
1.94
599
5089
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
604
5197
4.93
17.16
15.8
9.5
u/l
22.9
23.2
0.29
577
4922
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
373
2610
2.05
16.91
2.4
2.1
pmol/l
99.2
93.1
1.53
200
1278
(3022948) Iron [Moles/volume] in Serum or Plasma
166
865
2.25
16.45
3.6
2.4
umol/l
11.4
12.4
1.22
149
788
(3032080) INR in Blood by Coagulation assay
341
2331
2.01
16.27
13.3
11.3
inr
1.4
1.4
0.28
81
649
(3024731) MCV [Entitic volume]
612
5353
6.01
16.19
37.7
21.8
fl
92.4
91.8
2.90
607
5226
(3007461) Platelets [#/volume] in Blood
612
5354
6.01
16.16
37.8
21.8
e9/l
232.5
241.9
2.97
598
5164
(3026361) Erythrocytes [#/volume] in Blood
612
5355
6.00
16.13
37.8
21.8
e12/l
4.3
4.4
3.21
596
5139
(3035941) MCH [Entitic mass]
612
5355
6.00
16.13
37.6
21.7
pg
30.5
30.4
0.93
607
5228
(3010813) Leukocytes [#/volume] in Blood
612
5356
5.99
16.10
37.8
21.8
e9/l
7.2
6.8
1.16
597
5143
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
113
507
2.50
15.69
5.4
3.6
ng/l
103.4
92.6
0.66
98
429
(3013707) Erythrocyte sedimentation rate by Westergren method
487
3822
2.21
15.50
5.0
4.3
mm/h
15.7
14.2
1.00
436
3474
(3037467) Urinalysis macro (dipstick) panel - Urine
467
3621
2.12
15.11
6.9
4.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
307
2059
1.96
15.10
3.7
2.7
ug/l
135.2
130.7
0.16
277
1852
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
557
4659
2.69
14.81
5.6
5.0
mu/l
2.1
2.3
0.39
496
4142
(3026493) Urate [Moles/volume] in Serum or Plasma
220
1330
2.01
14.49
3.3
2.5
umol/l
11344.6
8575.7
0.21
182
1104
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
564
4767
2.75
14.28
7.2
7.0
mmol/mol
40.3
41.2
1.69
515
4327
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
57
188
3.23
14.02
3.0
1.4
g/l
0.5
0.4
0.19
50
155
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
238
1499
1.94
13.78
2.5
2.2
mg/l
2.9
3.0
0.48
205
1269
(3000494) Fungus identified in Specimen by Culture
114
543
2.34
13.76
1.6
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
250
1605
1.92
13.64
1.7
1.6
nmol/l
21.4
20.6
0.30
214
1356
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
90
392
2.51
13.21
2.1
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
74
295
2.71
12.98
1.9
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
100
461
2.39
12.96
8.9
5.2
mmol/l
1.2
1.5
2.25
95
443
(3044889) 12 lead EKG panel
465
3690
1.99
12.87
5.1
4.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
414
3168
1.89
12.69
6.4
4.1
mmol/l
6.7
6.9
1.06
399
2957
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
155
861
2.06
12.67
3.8
2.8
ug/l
0.8
0.8
0.37
119
609
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
54
186
3.08
12.35
3.1
1.4
g/l
37.6
37.2
0.24
48
149
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
114
569
2.23
12.24
3.9
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
170
994
1.97
11.96
2.2
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
574
4989
2.69
11.96
6.0
5.6
mmol/l
2.4
2.6
6.19
514
4459
(40761511) CBC panel - Blood by Automated count
578
5044
2.77
11.88
22.5
14.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
16
7
23.40
11.61
2.2
1.0
u/ml
18.8
14.6
—
16
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
58
4.63
11.04
1.4
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
82
372
2.38
10.96
1.6
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
43
5.27
10.86
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
71
306
2.49
10.60
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
121
3.37
10.58
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
121
3.37
10.58
1.6
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
95
470
2.20
10.35
1.4
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
95
471
2.20
10.29
2.4
1.6
g/l
64.1
66.5
2.73
88
415
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
552
4789
2.23
10.26
5.2
4.9
mmol/l
1.5
1.5
0.02
488
4261
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
289
2067
1.74
10.26
3.5
3.1
ng/l
2273.1
1712.8
0.97
246
1780
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
184
2.87
10.18
2.5
2.4
u/ml
0.4
0.4
0.15
27
110
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
97
488
2.17
10.13
3.3
2.2
umol/l
8.4
7.3
0.28
90
412
(46235355) HIV 1 and 2 tests - Meaningful Use set
79
365
2.33
10.12
1.7
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
358
2725
1.73
10.08
3.3
2.9
u/l
60.9
47.0
1.21
332
2436
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
184
1159
1.83
10.07
3.5
2.3
mmol/l
2.5
2.5
1.15
157
1000
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
215
2.71
10.00
3.1
1.4
g/l
3.0
3.1
0.55
48
165
(40768793) Breast Pathology biopsy report
19
35
5.57
9.98
1.4
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
116
3.33
9.88
1.5
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
536
4621
2.07
9.77
4.7
4.3
mmol/l
1.3
1.2
0.12
469
4054
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
553
4840
2.17
9.41
5.4
4.9
mmol/l
4.3
4.5
3.12
492
4336
(3051611) Lipemic interference index of Serum or Plasma
23
53
4.47
9.40
5.2
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
562
4955
2.24
9.30
5.8
5.3
mmol/l
6.1
6.1
0.86
495
4394
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
124
704
1.95
9.28
2.1
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
303
2237
1.68
9.27
2.6
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
44
159
2.90
9.27
4.6
3.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
188
1218
1.77
9.25
4.6
4.4
ng/l
163.9
307.1
0.86
173
1062
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
237
2.54
9.17
3.0
1.4
g/l
3.7
3.8
0.06
48
163
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
237
2.54
9.17
3.0
1.4
g/l
7.6
7.6
0.05
50
168
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
237
2.54
9.17
3.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
91
3.53
9.16
1.6
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
123
703
1.93
9.01
3.0
2.1
%
1.7
1.8
0.25
107
617
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
465
3870
1.77
8.92
4.3
4.0
pmol/l
15.0
15.2
1.05
400
3416
(3034860) Kappa light chains.free [Mass/volume] in Serum
49
193
2.67
8.79
3.8
1.4
mg/l
86.6
48.8
0.56
39
158
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
84
3.57
8.74
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
176
2.74
8.73
1.6
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
25
6.12
8.68
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
49
195
2.64
8.62
3.8
1.4
mg/l
32.1
39.4
0.55
40
159
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
204
1383
1.70
8.41
1.7
1.6
mmol/l
1.3
1.3
0.14
176
1137
(3026008) Bacteria identified in Urine by Culture
268
1969
1.63
8.00
4.4
3.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
47
4.36
7.99
1.6
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
35
122
2.98
7.87
2.5
2.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
29
92
3.26
7.63
1.6
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
118
703
1.83
7.53
2.1
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
115
680
1.85
7.51
9.8
5.2
mmol/l
104.5
104.1
0.41
115
663
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
68
3.63
7.48
1.6
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
79
413
2.04
7.41
2.6
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
127
780
1.79
7.31
1.4
1.3
g/l
3.0
2.8
0.24
63
425
(3000492) Spirometry study
68
339
2.13
7.23
2.1
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
195
1351
1.64
7.21
3.5
2.4
u/l
30.5
34.9
1.13
183
1279
(3023520) Reticulocytes [#/volume] in Blood
94
529
1.91
7.14
4.1
2.4
e9/l
68.0
67.6
0.03
56
425
(3009508) Creatinine [Moles/volume] in Urine
254
1885
1.58
7.03
4.2
3.1
mmol/l
6.1
6.7
1.38
208
1559
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
177
2.47
6.60
2.5
3.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
57
279
2.15
6.35
11.2
7.7
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
16
38
4.29
6.32
1.3
1.2
u/l
52.2
50.0
0.08
11
27
(3037121) Protein [Mass/volume] in Urine
42
181
2.41
6.30
3.8
2.4
g/l
0.2
0.3
0.39
20
44
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
28
99
2.91
6.18
1.8
2.0
%
94.0
85.5
1.35
28
94
(3048689) Calprotectin [Mass/mass] in Stool
83
470
1.88
6.17
2.1
1.9
ug/g
160.2
173.0
0.09
62
360
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
53
3.67
6.08
1.6
1.5
e6/l
20158.3
158456.2
—
10
31
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
100
2.88
6.07
1.9
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
100
2.88
6.07
1.6
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
246
1865
1.52
5.94
4.2
3.2
mg/l
146.3
176.7
0.12
160
1160
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
213
1568
1.54
5.88
6.2
4.1
ug/l
3.4
2.2
1.11
187
1378
(40768797) Stomach Pathology biopsy report
110
689
1.72
5.85
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
9
11.27
5.81
1.7
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
24
5.08
5.76
7.0
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
155
1066
1.60
5.74
1.7
1.6
mg/l
3.0
1.3
0.85
112
831
(3037522) Nuclear Ab [Titer] in Serum
95
574
1.77
5.73
1.5
1.3
titre
510.0
572.6
0.16
24
137
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
7
13.02
5.59
1.2
1.1
—
—
—
0
0
(4281824)
11
21
5.31
5.54
1.1
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
20
62
3.30
5.49
1.6
1.5
e6/l
913.1
2020.1
1.38
13
48
(3002032) Base excess in Venous blood by calculation
94
574
1.75
5.46
5.1
3.0
mmol/l
0.9
2.1
1.69
82
468
(3009343) pH of Capillary blood
62
333
1.96
5.40
4.8
3.8
ph
7.4
7.4
1.70
13
40
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
49
3.54
5.20
1.6
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
139
953
1.59
5.17
1.3
1.2
u/ml
0.9
1.6
1.08
20
241
(3010144) Erythrocytes [#/volume] in Synovial fluid
15
40
3.82
5.11
1.3
1.4
e6/l
23551.3
184222.9
—
8
27
(3014271) Vancomycin [Susceptibility]
12
27
4.51
5.05
3.0
2.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
62
341
1.91
5.04
4.9
3.8
kpa
5.2
5.2
0.14
56
309
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
105
2.64
5.03
1.4
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
314
2560
1.45
5.02
6.9
5.7
estimate
0.0
0.0
0.00
63
431
(3015736) pH of Urine
259
2038
1.46
4.99
4.0
4.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
69
396
1.83
4.93
7.0
4.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
56
3.28
4.92
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
32
137
2.41
4.91
1.8
1.6
e6/l
9302.5
13996.5
0.49
23
94
(3003396) Base excess in Arterial blood by calculation
103
666
1.65
4.84
8.9
5.4
mmol/l
1.0
1.4
0.43
85
513
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
138
2.39
4.83
1.6
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
61
339
1.89
4.82
4.8
3.4
%
0.8
0.7
0.11
17
58
(3020682) Albumin/Creatinine [Ratio] in Urine
252
1987
1.45
4.74
5.4
3.9
mg/mmol
11.8
8.0
0.63
160
1224
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
319
1.90
4.73
4.9
3.7
mmol/l
1.8
2.1
0.24
46
233
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
103
671
1.64
4.70
8.9
5.4
kpa
5.2
5.1
0.59
98
640
(3027801) Oxygen [Partial pressure] in Arterial blood
103
671
1.64
4.70
8.9
5.3
kpa
13.2
11.3
3.19
97
638
(1002224) Polysomnography panel
28
115
2.50
4.69
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
315
2594
1.43
4.65
4.8
4.2
estimate
0.0
0.0
0.50
62
437
(3025159) Blasts/100 leukocytes in Blood
60
336
1.87
4.63
5.0
3.4
%
0.2
1.4
0.40
18
61
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
450
1.76
4.63
6.8
2.7
mmol/l
1.2
1.2
0.79
64
375
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
207
1581
1.46
4.57
2.8
2.2
u/l
56.6
58.3
0.29
188
1429
(3017446) Testosterone [Moles/volume] in Serum or Plasma
39
188
2.15
4.56
2.2
2.2
nmol/l
9.6
14.8
2.27
32
162
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
93
2.64
4.52
6.9
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
310
2555
1.42
4.50
4.8
4.2
estimate
0.0
0.0
0.00
67
442
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
76
2.82
4.49
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
30
4.06
4.45
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
30
4.06
4.45
1.1
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
26
106
2.52
4.43
1.6
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
50
3.26
4.36
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
16
50
3.26
4.36
1.8
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
171
1269
1.48
4.34
5.0
4.1
%
24.0
25.0
0.31
95
652
(3021440) Promyelocytes/100 leukocytes in Blood
61
351
1.82
4.33
4.9
3.4
%
0.1
0.0
0.09
17
70
(3021788) Differential panel - Synovial fluid
27
114
2.43
4.29
1.8
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
126
883
1.53
4.20
45.5
31.7
inr
1.6
1.5
—
7
111
(3045142) Bone marrow Pathology biopsy report
12
32
3.80
4.10
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
10
8.09
4.07
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
234
1.95
3.98
2.4
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
62
369
1.75
3.95
5.1
3.3
%
1.2
0.7
0.39
17
79
(3044941) Cell count panel - Synovial fluid
24
100
2.46
3.94
1.9
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
76
2.69
3.93
4.7
2.4
%
51.9
59.6
1.44
20
76
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
42
221
1.96
3.92
2.2
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
29
3.84
3.81
2.6
1.3
ug/l
20.8
15.6
0.30
11
29
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
8
8.83
3.78
11.3
8.1
mmol/l
4.6
6.2
—
7
8
(40760888) Immunoglobulin light chains.free panel - Serum
30
142
2.17
3.71
4.2
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
23
97
2.42
3.69
3.1
1.9
%
62.5
59.8
0.16
23
97
(36660697) Celiac disease serology panel - Serum
57
339
1.75
3.65
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
68
2.70
3.59
1.6
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
439
3920
1.40
3.59
34.9
20.2
g/l
329.7
331.1
2.54
434
3884
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
228
1839
1.38
3.52
2.6
2.2
u/l
176.3
257.0
0.87
213
1715
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
13
6.22
3.51
1.6
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
13
6.22
3.51
1.6
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
13
6.22
3.51
1.6
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
179
1393
1.40
3.42
2.0
1.8
nmol/l
1144.3
1178.4
0.17
125
1035
(3022313) Gas panel - Capillary blood
43
243
1.83
3.28
5.1
4.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
19
4.79
3.25
1.9
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
73
2.51
3.15
3.4
2.1
e9/l
3.4
4.6
1.89
18
73
(3011397) Hemoglobin [Presence] in Urine by Test strip
166
1292
1.39
3.14
3.7
4.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
92
2.33
3.13
1.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
8
7.56
3.06
3.3
1.0
u/ml
19.0
20.6
—
6
8
(40768795) Lymph node Pathology biopsy report
7
12
5.88
3.02
1.1
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
135
2.04
2.95
1.1
1.4
ug/g
287.7
292.3
0.04
12
81
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
58
2.62
2.89
1.7
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
33
179
1.89
2.88
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
13
5.43
2.87
1.7
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
47
2.80
2.83
2.2
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
31
3.26
2.78
1.5
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
42
2.89
2.76
1.5
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
189
1.84
2.76
1.1
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.39
2.75
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
6
8.39
2.75
1.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
14
5.04
2.73
1.1
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
90
647
1.46
2.64
2.6
3.2
ng/l
275.9
236.0
0.26
84
593
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
142
1.94
2.59
1.5
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
38
2.93
2.59
1.6
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
49
309
1.64
2.59
1.6
1.5
%
1.7
1.6
0.24
42
260
(4034850)
7
194
0.35
2.58
10.4
11.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
20
4.04
2.57
1.6
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
20
4.04
2.57
1.6
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
20
4.04
2.57
1.6
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
20
4.04
2.57
1.6
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
44
2.76
2.56
1.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
53
342
1.60
2.55
1.5
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
90
1211
0.70
2.53
5.0
4.6
kg/l
1.0
1.0
1.47
16
191
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
16
4.41
2.48
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
16
4.41
2.48
1.0
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
63
2.41
2.48
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
51
2.58
2.45
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
12
5.04
2.40
2.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
505
1.48
2.40
1.5
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
40
2.78
2.38
1.1
1.0
g/l
1.4
1.6
0.65
11
35
(3036481) Cortisol [Moles/volume] in Serum or Plasma
65
449
1.50
2.34
3.4
1.7
nmol/l
345.5
366.1
0.35
60
396
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
35
2.89
2.31
2.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
53
2.48
2.29
1.1
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
60
2.36
2.23
1.4
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
9
5.59
2.21
1.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
9
5.59
2.21
1.4
1.2
umol/l
61.2
56.3
—
5
9
(3035637) Corticotropin [Mass/volume] in Plasma
10
36
2.81
2.21
2.4
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
42
2.65
2.19
1.6
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
31
181
1.75
2.19
3.6
3.6
nmol/l
0.7
0.8
1.30
24
146
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
220
1.67
2.17
4.5
2.8
pmol/l
4.1
4.4
1.52
29
186
(3019225) pH of Specimen
78
572
1.42
2.08
6.4
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
132
1053
1.32
2.08
1.3
1.3
—
—
—
0
0
(4015189)
7
21
3.36
1.97
1.6
2.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
21
3.36
1.97
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
51
2.38
1.96
1.2
1.1
—
—
—
0
0
(44790048)
11
45
2.47
1.94
1.9
1.2
—
—
—
0
0
(44806118)
11
45
2.47
1.94
1.9
1.2
—
—
—
0
0
(44790047)
11
45
2.47
1.94
1.9
1.2
—
—
—
0
0
(44790049)
11
45
2.47
1.94
1.9
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
113
1.89
1.94
4.1
3.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
47
317
1.52
1.92
1.3
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
22
121
1.85
1.90
3.8
3.6
mmol/l
2.7
3.0
0.27
14
81
(3003327) Ova and parasites identified in Stool by Light microscopy
21
114
1.87
1.89
2.0
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
129
1.81
1.88
2.3
1.9
g/l
121.3
131.3
1.01
16
94
(4094501)
23
130
1.80
1.84
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
23
3.07
1.80
1.0
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
194
0.46
1.75
5.2
3.8
mmol/l
3.3
3.9
—
9
182
(3016018) Differential panel - Cerebral spinal fluid
9
36
2.52
1.74
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
36
2.52
1.74
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
30
2.69
1.73
1.1
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
21
118
1.81
1.72
2.8
2.2
%
15.3
15.9
0.34
15
57
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
75
2.02
1.71
1.6
1.2
—
—
—
0
0
(3013512) EKG study
199
1711
1.24
1.70
4.9
4.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
149
1.71
1.69
3.6
2.4
ug/min
45.4
58.6
0.16
15
95
(3036603) Volume of Urine
6
19
3.18
1.66
1.0
1.7
—
1674.7
—
0
6
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
23
135
1.73
1.64
1.1
1.2
—
59.2
—
0
6
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
262
2329
1.21
1.60
4.6
4.2
ng/l
31.3
61.1
1.33
210
1795
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
32
2.52
1.60
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
32
2.52
1.60
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
32
2.52
1.60
1.6
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
32
2.52
1.60
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
64
477
1.38
1.59
1.3
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
20
3.02
1.58
1.0
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
26
2.71
1.58
1.7
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
50
2.22
1.57
2.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
33
2.44
1.54
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
33
2.44
1.54
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
33
2.44
1.54
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
21
2.87
1.51
3.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.51
1.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.51
1.0
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
21
2.87
1.51
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
16
3.14
1.44
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
39
2.33
1.43
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
53
393
1.38
1.38
3.3
2.4
ml/min/173m2
49.7
55.5
0.53
27
165
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
175
1.57
1.36
1.3
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
17
2.96
1.36
2.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
47
2.15
1.34
1.1
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
68
1.93
1.34
1.5
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
41
293
1.43
1.32
3.0
3.0
e9/l
4.3
4.0
0.23
25
201
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
24
2.51
1.30
1.5
1.4
g/l
1.0
0.9
—
6
24
(3016879) Cocaine [Presence] in Urine
8
34
2.37
1.29
1.6
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
34
2.37
1.29
1.6
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
34
2.37
1.29
1.6
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
25
2.41
1.24
2.0
3.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
36
2.24
1.24
1.1
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.24
1.8
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
45
2.01
1.23
4.6
2.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
37
2.18
1.21
1.6
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
37
2.18
1.21
1.6
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
37
2.18
1.21
1.6
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
20
125
1.62
1.19
1.1
1.2
—
3.7
—
0
17
(3017704) Immunofixation for Urine
8
38
2.12
1.18
1.4
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
20
2.51
1.15
1.4
1.4
umol/l
24.8
21.8
—
5
20
(3028707) Methadone [Presence] in Urine by Screen method
5
20
2.51
1.15
2.0
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
60
759
0.77
1.15
9.4
8.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
65
1.86
1.14
2.2
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
30
2.35
1.12
1.0
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
20
128
1.58
1.09
1.1
1.2
—
3.7
—
0
23
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
32
2.20
1.08
1.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
27
186
1.47
1.08
1.0
1.1
—
164.2
—
0
5
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
137
1.55
1.07
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
52
1.94
1.06
1.3
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
108
915
1.22
1.06
5.5
3.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
83
1.70
1.02
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
378
0.70
1.01
4.0
3.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
50
1.81
0.97
1.1
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
338
0.70
0.94
7.8
4.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
159
1.46
0.92
1.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
28
2.15
0.91
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
64
1.73
0.86
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
64
1.73
0.86
1.7
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
112
1.53
0.85
1.0
1.2
—
3.6
—
0
7
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
767
1.20
0.85
1.2
1.2
u/ml
13.7
14.1
0.02
16
258
(3021901) Oxygen saturation in Capillary blood
16
104
1.55
0.85
2.9
2.7
—
—
—
0
0
(3020891) Body temperature
17
250
0.67
0.85
4.5
3.8
—
—
—
0
0
(3035880) pH of Pleural fluid
6
31
1.94
0.84
1.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
57
1.77
0.84
2.7
3.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
33
1.83
0.79
1.8
1.3
—
—
—
0
0
(4027681)
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
1.2
—
0
18
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
2.0
—
60.7
—
0
20
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
24
2.09
0.74
1.2
1.3
u/l
201.0
210.8
—
5
24
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
602
1.20
0.72
2.3
2.6
ug/l
8.1
6.6
0.29
55
516
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
56
1.62
0.72
1.1
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
29
221
1.33
0.71
2.3
2.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
119
1.44
0.67
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
43
1.63
0.67
2.0
2.0
mu/l
370.0
286.1
—
7
38
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
7
43
1.63
0.67
1.0
1.0
—
2.7
—
0
15
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
44
1.60
0.65
4.4
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
90
789
1.16
0.64
1.2
1.3
iu/ml
61.0
46.0
0.19
23
257
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
29
1.73
0.64
1.8
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
5
29
1.73
0.64
1.8
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
127
1405
0.88
0.63
1.9
1.8
pmol/l
417.3
10327003.3
0.80
93
1133
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.0
1.4
—
—
—
0
0
(4024509)
8
51
1.58
0.60
2.0
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
20
0.00
0.60
0.0
6.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
228
1.29
0.59
1.5
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
72
1.54
0.59
1.2
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
24
308
0.77
0.57
5.5
3.2
%
48.3
47.3
0.06
24
303
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
36
1.67
0.57
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
706
1.15
0.54
5.4
5.1
%
36.4
33.9
1.23
53
439
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
182
1953
0.90
0.53
5.9
4.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
100
0.60
0.52
1.5
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
100
0.60
0.52
1.5
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
41
345
1.20
0.49
2.7
2.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
46
1.53
0.48
1.1
1.4
%
12.2
10.6
—
7
46
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
120
1.34
0.46
1.5
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
138
1.31
0.46
1.4
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
501
0.85
0.45
4.6
3.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
158
1.27
0.42
2.6
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
70
1.44
0.42
1.2
1.1
nmol/l
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
18
0.00
0.40
0.0
5.2
—
25.0
—
0
18
(4306422)
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
25.4
—
0
5
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
151
1.27
0.39
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
151
1.27
0.39
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
36
1.39
0.38
6.2
13.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
89
1.36
0.38
1.5
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
90
1.34
0.36
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
153
1.25
0.35
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
43
1.40
0.35
1.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
73
1.38
0.34
1.2
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
73
1.38
0.34
1.5
1.6
%
88.8
90.0
—
10
73
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
138
1299
1.08
0.32
4.1
3.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
139
0.79
0.27
3.4
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
104
1.26
0.26
1.4
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
74
0.67
0.26
4.2
5.1
mmol/l
6.0
7.6
—
5
61
(1761482) Bacteria [#/volume] in Urine by Culture
15
181
0.82
0.25
8.2
5.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
75
1.20
0.25
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
135
1287
1.06
0.23
6.1
3.9
—
—
—
0
0
(4062490)
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
93
0.75
0.22
2.0
2.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
94
0.74
0.22
2.0
2.3
mmol/l
108.7
105.2
—
7
94
(3041354) Potassium [Moles/volume] in Venous blood
7
94
0.74
0.22
2.0
2.3
mmol/l
4.4
4.1
—
7
94
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
126
1.20
0.21
1.0
1.1
—
21.9
—
0
6
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
51
1.18
0.19
1.2
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
59
1.19
0.18
2.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
60
1.17
0.18
2.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
60
1.17
0.18
2.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
2.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
2.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
61
1.15
0.17
2.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
173
0.86
0.17
1.8
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
49
457
1.08
0.16
1.8
1.5
—
—
—
0
0
(4146454)
8
70
1.14
0.16
1.8
2.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
25
228
1.10
0.13
1.7
1.6
ug/l
0.5
1.9
1.88
19
196
(3029937) Albumin [Presence] in Urine by Test strip
144
1405
1.03
0.10
5.5
4.6
estimate
0.0
0.0
0.00
61
424
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
43
410
1.05
0.08
3.4
3.8
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
60
0.83
0.08
2.0
1.3
nmol/l
401.4
355.2
—
5
51
(3005570) Glucose [Moles/volume] in Urine
7
68
1.03
0.08
1.7
2.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
72
0.83
0.07
1.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
75
1.07
0.07
3.8
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
99
1.11
0.06
1.3
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
12
109
1.10
0.06
1.2
1.3
e6/l
31.7
1284.1
—
6
96
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
12
109
1.10
0.06
1.1
1.2
e6/l
3.7
80.1
—
6
94
(3030981) Hyaline casts [#/volume] in Urine by Automated count
26
274
0.95
0.06
5.3
2.5
e6/l
0.4
0.2
0.33
26
264
(4010399)
41
400
1.03
0.02
1.6
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
93
1.08
0.02
1.4
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
113
1.06
0.02
1.6
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
13
123
1.06
0.01
1.3
1.3
mg/l
480.5
534.0
0.38
13
115
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
116
0.95
0.00
1.7
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
185
1.03
0.00
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
225
1.02
0.00
1.3
1.2
iu/ml
150.8
116.9
—
9
79
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.1
—
81.1
—
0
9
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
49
1.02
0.00
1.2
1.3
mmol/l
6.7
7.5
—
5
37
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
65
0.92
0.00
1.5
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
6.4
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
91
0.99
0.00
1.1
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
61
0.98
0.00
5.0
3.4
umol/l
294.0
339.3
—
6
51
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
63
0.95
0.00
1.5
1.6
u/ml
30.5
121.8
—
6
57
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
79
1.01
0.00
1.3
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
13.4
—
1467.3
—
0
7
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
10.3
—
776.4
—
0
7
(4198724)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_SKIN_LOWERLIMB_EXALLC – Carcinoma in situ of skin of lower limb, including hip

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).